SomaLogic's Series F Round

SomaLogic raised a round of funding on January 05, 2017. Investors include iCarbonX.

SomaLogic is a protein biomarker discovery and clinical diagnostics company leveraging its Slow Off-rate Modified Aptamer (SOMAmer) technology. The company aims to develop and commercialize breakthrou…

Articles about SomaLogic's Series F Round: